Getting regenerative medical biotech redi to age - the potential outcomes of this application include: (1) curriculum development and the creation of internship opportunities within an…

Active Project Grant Awarded Last action

Award ID
R25AG078151
Recipient
Awarding agency
Obligated
$901,404

Award facts

Assistance listing
93.866 Aging Research
Completion date 87% complete
Place of performance
New Orleans, LA 70148, USA

Award details come from USAspending.gov.

Description

Getting regenerative medical biotech redi to age - the potential outcomes of this application include: (1) curriculum development and the creation of internship opportunities within an entrepreneurship in biotechnology focused program; (2) a greater representation of diverse researchers within biotech entrepreneurship in southeast louisiana with the potential to expand across the U.S.; (3) a tangible number of students from diverse backgrounds who can go on to pursue advance degrees and employment opportunities within the biotechnology sector; and (4) a pipeline of individuals who will value the importance of the responsible conduct of research, and apply those ethics to create their own companies as entrepreneurs, or their own training programs as educators or researchers within various biotechnology fields. This small business innovation research application addresses an identified challenge and unmet GAP in curriculum development that combines exposure to fundamental concepts in both biotechnology research and entrepreneurial development and provides a pathway to create opportunities for a more diverse workforce. Unlike existing curricula, the proposed programming does not have the goal of promoting careers exclusively in academia or biotechnology. The intention is to leverage the diverse background and training of professionals at obatala sciences, delgado community college, xavier university of louisiana, and the university of new orleans, to give students greater insight into the opportunities that exist and the relevance of maintaining the responsible conduct of research within all stages of their career. Such a program is a complement to any set of traditional business and/or research courses and provides a mechanism to reinforce some of the necessary elements of success within research in biotechnology and entrepreneurship. Obatala anticipates achievement of the following outcomes: firstly, IT will implement coursework and accompanying teaching tools that focus on entrepreneurship in biotechnology and are adaptable across multiple teaching platforms and programs that are designed to give greater exposure to opportunities in entrepreneurship. Secondly, IT will create a pipeline of interns and professionals who can apply lessons learned from their executive MBA or entrepreneurship programs to multiple facets of their careers and take these fundamentals with them to other opportunities throughout the nation. Thirdly, IT will create a success metric that can be applied to programs that are designed to promote diversity in research and entrepreneurship. By incorporating one or all of these innovations to the current approach to teaching biotechnology, obatala will introduce an adaptable teaching model with impacts spanning academic and industry researchers and entrepreneurs, across fields including therapeutics and regenerative medicine. Obatala will position itself as a leader that not only promotes diversity in research, but also in training the next generation of researchers and promoting the highest standards of ethics and the responsible conduct of research. Such activity has potential to positively impact the current perception of the role of entrepreneurship in research in a global scale.

Transactions

Action Obligated Date
Amendment $150,234
Amendment $150,234
Amendment $150,234
Amendment $150,234
Amendment $150,234
Original award $150,234

Quick answers

Who received award R25AG078151?

R25AG078151 was awarded to Obatala Sciences Inc. by National Institute on Aging (National Institutes of Health) on September 1, 2022.

How much is award R25AG078151 worth?

$901,404 has been obligated on R25AG078151.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award